Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Methylphenidate for medical in-patients.

R Z Fisch

    International Journal of Psychiatry in Medicine
    |January 1, 1985
    PubMed
    Summary

    Methylphenidate (Ritalin Hydrochloride) offers a safe and rapid treatment option for depression in medically ill and geriatric patients. This antidepressant can be discontinued without withdrawal effects, showing at least 50% success.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Cultural elements of postpartum depression. A study of 327 Jewish Jerusalem women.

    The Journal of reproductive medicine·2000
    Same author

    Postnatal depression: a prospective study of its prevalence, incidence and psychosocial determinants in an Israeli sample.

    The journal of obstetrics and gynaecology research·1998
    Same author

    Psychosis precipitated by marriage: a culture-bound syndrome?

    The British journal of medical psychology·1992
    Same author

    [Psychiatry in medicine: how to save a lot of money with a small investment; or: how to waste a lot of money by trying to cut edges?].

    Harefuah·1991
    Same author

    Drug induced suicidal ideation.

    The Israel journal of psychiatry and related sciences·1991
    Same author

    Attempted suicide: a study of 133 cases in Jerusalem.

    The Israel journal of psychiatry and related sciences·1990

    Area of Science:

    • Geriatric Medicine
    • Psychiatry
    • Clinical Pharmacology

    Background:

    • Depression in medically ill and geriatric populations presents unique treatment challenges.
    • Traditional antidepressants may be contraindicated or poorly tolerated in these patient groups.
    • Need for safe, rapidly acting, and easily discontinued antidepressant therapies.

    Observation:

    • Methylphenidate (Ritalin Hydrochloride) was investigated for its efficacy and safety in treating depression.
    • The study focused on patients with medical conditions and elderly individuals.
    • Safety profile, rapid onset, and lack of withdrawal symptoms were key considerations.

    Findings:

    • Methylphenidate demonstrated a favorable safety profile in medically ill patients with depression.
    • The drug exhibited a quick onset of action, addressing depressive symptoms promptly.
    • Treatment discontinuation did not result in a recurrence of depression.
    • A success rate of at least 50% was reported in the treated patient cohort.

    Implications:

    • Methylphenidate presents a viable alternative for managing depression in medically complex patients.
    • Its safety and rapid action profile make it suitable for individuals intolerant to other antidepressants.
    • The potential for short-term use without withdrawal offers therapeutic flexibility.

    Related Experiment Videos